Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study

Thomas  Purchase; George Trilloe; Haroon Ahmed; Ridhi Agarwal; Alison Bray; Karenza Hood; Emma Thomas-Jones; Marcus J Drake; Chris Harding; Adrian  Edwards

doi:10.1016/j.euf.2022.01.001

Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study

Thomas Purchase^*, George Trilloe, Haroon Ahmed , Ridhi Agarwal, Alison Bray, Karenza Hood, Emma Thomas-Jones, Marcus J Drake, Chris Harding, Adrian Edwards

^*Corresponding author for this work

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

3 Citations (Scopus)

48 Downloads (Pure)

Original language	English
Pages (from-to)	8-10
Number of pages	3
Journal	European Urology Focus
Volume	8
Issue number	1
Early online date	20 Jan 2022
DOIs	https://doi.org/10.1016/j.euf.2022.01.001
Publication status	Published - 22 Feb 2022

Bibliographical note

Funding Information:
Acknowledgements: This research was part of the wider PriMUS study, which was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (reference: 15-40-05).

Keywords

Polypharmacy
smoking
lower urinary tract symptoms
PriMUS

Access to Document

10.1016/j.euf.2022.01.001

Full-text PDF (author’s accepted manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at https://doi.org/10.1016/j.euf.2022.01.001 . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 198 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

Purchase, T., Trilloe, G., Ahmed , H., Agarwal, R., Bray, A., Hood, K., Thomas-Jones, E., Drake, M. J., Harding, C., & Edwards, A. (2022). Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study. European Urology Focus, 8(1), 8-10. https://doi.org/10.1016/j.euf.2022.01.001

@article{79d0b79bd1614524a87f2af3ab64753f,

title = "Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study",

keywords = "Polypharmacy, smoking, lower urinary tract symptoms, PriMUS",

author = "Thomas Purchase and George Trilloe and Haroon Ahmed and Ridhi Agarwal and Alison Bray and Karenza Hood and Emma Thomas-Jones and Drake, {Marcus J} and Chris Harding and Adrian Edwards",

note = "Funding Information: Acknowledgements: This research was part of the wider PriMUS study, which was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (reference: 15-40-05).",

year = "2022",

month = feb,

day = "22",

doi = "10.1016/j.euf.2022.01.001",

language = "English",

volume = "8",

pages = "8--10",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier B.V.",

number = "1",

}

Purchase, T, Trilloe, G, Ahmed , H, Agarwal, R, Bray, A, Hood, K, Thomas-Jones, E, Drake, MJ, Harding, C & Edwards, A 2022, 'Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study', European Urology Focus, vol. 8, no. 1, pp. 8-10. https://doi.org/10.1016/j.euf.2022.01.001

Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study. / Purchase, Thomas ; Trilloe, George; Ahmed , Haroon et al.
In: European Urology Focus, Vol. 8, No. 1, 22.02.2022, p. 8-10.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care

T2 - Findings from the PriMUS Study

AU - Purchase, Thomas

AU - Trilloe, George

AU - Ahmed , Haroon

AU - Agarwal, Ridhi

AU - Bray, Alison

AU - Hood, Karenza

AU - Thomas-Jones, Emma

AU - Drake, Marcus J

AU - Harding, Chris

AU - Edwards, Adrian

N1 - Funding Information: Acknowledgements: This research was part of the wider PriMUS study, which was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (reference: 15-40-05).

PY - 2022/2/22

Y1 - 2022/2/22

KW - Polypharmacy

KW - smoking

KW - lower urinary tract symptoms

KW - PriMUS

U2 - 10.1016/j.euf.2022.01.001

DO - 10.1016/j.euf.2022.01.001

M3 - Article (Academic Journal)

C2 - 35065904

SN - 2405-4569

VL - 8

SP - 8

EP - 10

JO - European Urology Focus

JF - European Urology Focus

IS - 1

ER -